The RAF-MEK-ERK pathway drives several features of oncogenic transformation, and BRAF is an oncogene in its own right that is frequently mutated in melanoma, colorectal cancer, and lung cancer, amongst others [5,6]. This evidence concerns the gene BRAF and melanoma.